About this trial
Aim of this study is to characterize the chemical/physical and structural parameters of the skin in patients with breast cancer undergoing oncological adjuvant treatment in order to understand how to prevent and manage adverse skin events during hormone therapy, also through the formulation of new functional dermocosmetics.
Eligibility criteria
Qualifiers
age between 40 and 70 years
subjects who are receiving treatment with tamoxifen, aromatase inhibitor or paclitaxel in adjuvant therapy +/- adjuvant radiotherapy
subjects who are receiving hormonal therapy must have suspended any chemotherapy for at least 30 days
Disqualifiers
presence of known chronic skin pathologies before adjuvant treatment start (psoriasis, lupus, atopic dermatitis)
inability to understand and will
unavailability to carry out all the tests required by the protocol
Trial design
Treatments tested in this trial
- Skin tests